#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fragile X syndrome Small cell lung cancer extensive stage Acute leukaemia Immunodeficiency common variable Acute respiratory distress syndrome Osteomyelitis Kidney transplant rejection Chronic kidney disease Mucopolysaccharidosis I Narcolepsy Immunodeficiency congenital Diffuse large B-cell lymphoma Leiomyosarcoma Metachromatic leukodystrophy Acute promyelocytic leukaemia More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Trials in Disease Gaucher’s disease type III – Treatment Congenital hypotransferrinaemia – Diagnostics Malignant fibrous histiocytoma – Treatment Burkitt’s lymphoma – Trials in Disease Sarcoidosis – Diagnostics Retinitis pigmentosa – Basic Information Cytokine release syndrome – Diagnostics Familial haemophagocytic lymphohistiocytosis – Basic Information Erdheim-Chester disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MEGESTROL ACETATE Linerixibat Allo-501A Cladribine Lisaftoclax Anitocabtagene Autoleucel Rugonersen Other Immunosuppressants Lsta1 Omp66 Febuxostat Dorocubicel Burfiralimab Rituximab Elvn-002-1 Bp1.7881A Ivacaftor Timothy Grass Pollen Extract Ambrisentan Certolizumab Pegol More therapies…

    Learn about Your Condition

    Aphthous ulcer Prader-Willi syndrome Cervix carcinoma recurrent Limb reduction defect Hypertrophic cardiomyopathy Neutropenia Dementia Chordoma Endometrial cancer stage III Cardiac failure chronic Ovarian cancer stage III Malignant mast cell neoplasm H1N1 influenza Endometrial cancer stage II Lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Methylprednisolone and Prednisone for Treating Acute Flare-Ups in Idiopathic Pulmonary Fibrosis Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Methylprednisolone Hydrogen Succinate
    • Prednisone
    • Sodium Chloride
    France

  • Study of OSE-279 and OSE2101 Drug Combination for Patients with Advanced Solid Tumors, Lymphomas, or Metastatic Non-Small Cell Lung Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lymphoma
    • Squamous cell carcinoma of lung
    • Neoplasm malignant
    Investigated Drugs:
    • Imsidolimab
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    Belgium France Spain

  • Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer metastatic
    Investigated Drugs:
    • Capecitabine
    • Dostarlimab
    • Oxaliplatin
    Belgium Italy Spain

  • Study on Apixaban for Blood Clot Prevention in New Multiple Myeloma Patients and Those Having Knee Replacement Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Apixaban
    France

  • Comparing Anakinra versus Immunoglobulin for Treatment-Resistant Kawasaki Disease in Patients Who Failed Initial Immunoglobulin Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Kawasaki’s disease
    Investigated Drugs:
    • Anakinra
    • Human Normal Immunoglobulin
    France

  • Study on Insulin Eye Drops for Treating Persistent Corneal Epithelial Defect in Patients with Neurotrophic or Chronic Ocular Surface Diseases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Persistent corneal epithelial defect
    Investigated Drugs:
    • Insulin Human
    Spain
Previous Page
1 … 407 408 409 410 411 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!